CMS proposes prior authorization overhaul

Prior authorization is the insurance checkpoint that makes doctors ask permission before a drug or service gets covered. Everyone in healthcare knows the complaint — it slows care, burns staff time, and often feels arbitrary. CMS is now trying to fix a big missing piece. On April 10, 2026, the agency proposed a rule that would take the electronic prior authorization framework it already built for medical services and extend much of it to prescription drugs. ### What actually changed? The new proposal is called CMS-0062-P. It would require the same broad group of “impacted payers” — Medicare Advantage plans, Medicaid and CHIP fee-for-service programs, Medicaid and CHIP managed care plans, and federally facilitated exchange issuers — to support electronic prior authorization for drugs, not just non-drug items and services. CMS also wants to add small-group FF-SHOP exchange issuers to that list. (cms.gov) ### Why were drugs left out before? The 2024 final rule, CMS-0057-F, was a big prior auth overhaul, but it mostly focused on non-drug services. CMS said then that drug workflows were different enough that they needed separate treatment. So the current proposal is less a surprise than a second chapter — the agency built the rails first, then came back for pharmacy. (cms.gov) ### What would plans have to do? Basically, plans would need to make drug prior auth work electronically through standardized APIs instead of phone calls, fax loops, and portal hopping. CMS also wants shorter, aligned decision timeframes for drug requests, more transparency around prior auth operations, updated health IT standards, and reporting on API endpoints and usage. That last part matters because CMS is not just asking plans to build the pipes — it wants evidence that the pipes are actually being used. (cms.gov) ### Does this mean instant approvals? No — and that’s the catch. The rule does not kill prior authorization. It digitizes and standardizes it. Think of it less like removing a tollbooth and more like replacing a handwritten checkpoint with an electronic lane. You still may get stopped, but the process should be faster, more legible, and easier to track. CMS’s earlier rule already set a 72-hour deadline for urgent requests and seven calendar days for standard ones for covered plans, with most API requirements landing by January 1, 2027. (cms.gov) ### Why is CMS still pushing on this? Because the burden is still huge. AMA survey results show physicians overwhelmingly say prior authorization delays care and drives burnout. On the Medicare Advantage side, KFF found nearly 53 million prior authorization determinations in 2024, while only a small share of denials were appealed — even though most appealed denials were overturned. That is a sign of friction, not confidence. (cms.gov) ### Who feels this first? Doctors’ offices, hospital authorization teams, pharmacies, and patients on time-sensitive medications. Medicare Advantage and Medicaid managed care are especially important here because they touch a huge share of seniors, disabled patients, and lower-income families. When prior auth drags, treatment can drift from “annoying delay” into “missed care window.” Electronic workflows cannot solve every coverage fight, but they can cut some of the administrative dead time. (ama-assn.org) ### What happens next? It’s still a proposed rule. The Federal Register posting says comments are due by June 15, 2026. So the real story right now is direction, not final enforcement. CMS is signaling that prior authorization reform is no longer just about medical services — pharmacy is next. ### Bottom line? (cms.gov) CMS is trying to turn prior authorization from a patchwork of faxes, portals, and manual work into a standard digital transaction. That will not end denials. But it could make the system less slow, less opaque, and a little harder for avoidable paperwork to masquerade as medical management. (federalregister.gov)